World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
109
Citations
48637
World Ranking
998
National Ranking
607

Medicine

D-Index
110
Citations
50888
World Ranking
5502
National Ranking
2965

Overview

James B. Bussel is affiliated with Cornell University in the United States. Their research primarily spans the field of Medicine with a strong focus on Hematology. Other related subfields in which they have contributed include Genetics, Surgery, Immunology, and Pathology and Forensic Medicine.

The main topics of their work involve platelet disorders and treatments, blood groups and transfusion, autoimmune bullous skin diseases, heparin-induced thrombocytopenia and thrombosis, chronic lymphocytic leukemia research, immunodeficiency and autoimmune disorders, and blood properties and coagulation.

Frequent publication venues for their research include:

  • Blood
  • British Journal of Haematology
  • American Journal of Hematology
  • Blood Advances
  • New England Journal of Medicine

James B. Bussel has collaborated extensively with several co-authors, including:

  • Nichola Cooper
  • Waleed Ghanima
  • David J. Kuter
  • Douglas B. Cines
  • Marc Michel

Representative recent papers authored or co-authored by Bussel include:

  • "SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia" (2021) published in New England Journal of Medicine
  • "COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City" (2020) published in Modern Pathology
  • "Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination" (2021) published in American Journal of Hematology
  • "Neonatal Fc receptor in human immunity: Function and role in therapeutic intervention" (2020) published in Journal of Allergy and Clinical Immunology
  • "Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia" (2020) published in Blood Advances

Best Publications

  • Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

    Francesco Rodeghiero;Roberto Stasi;Terry Gernsheimer;Marc Michel

  • International consensus report on the investigation and management of primary immune thrombocytopenia.

    Drew Provan;Roberto Stasi;Adrian C. Newland;Victor S. Blanchette

  • Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.

    JN George;SH Woolf;GE Raskob;JS Wasser

  • Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

    David J. Kuter;James B. Bussel;Roger M. Lyons;Vinod Pullarkat

  • The ITP syndrome: pathogenic and clinical diversity

    Douglas B. Cines;James B. Bussel;Howard A. Liebman;Eline T. Luning Prak

  • Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.

    James B Bussel;Gregory Cheng;Mansoor N Saleh;Bethan Psaila

  • B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen

    Irene Puga;Montserrat Cols;Carolina M. Barra;Bing-Yang He

  • Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

    Gregory Cheng;Mansoor N Saleh;Claus Marcher;Sandra Vasey

  • AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.

    James B. Bussel;David J. Kuter;James N. George;Robert McMillan

  • Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.

    James B Bussel;Drew Provan;Tahir Shamsi;Gregory Cheng

  • Safety and efficacy of long-term treatment with romiplostim in thrombocytopenic patients with chronic ITP.

    James B. Bussel;David J. Kuter;Vinod Pullarkat;Roger M. Lyons

  • Treatment of refractory immune thrombocytopenic purpura with an anti-Fcγ-receptor antibody

    Sarah B. Clarkson;James B. Bussel;Robert P. Kimberly;Jay E. Valinsky

  • Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell–stimulating programs in basophils

    Kang Chen;Weifeng Xu;Melanie Wilson;Bing He

  • SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.

    Douglas B. Cines;James B. Bussel

  • How I treat idiopathic thrombocytopenic purpura (ITP)

    Douglas B. Cines;James B. Bussel

  • Intravenous Anti-D Treatment of Immune Thrombocytopenic Purpura: Experience in 272 Patients

    Andromachi Scaradavou;Bonnie Woo;B.M.R. Woloski;Susanna Cunningham-Rundles

  • Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

    Roberto Stasi;Ameet Sarpatwari;Jodi B. Segal;John Osborn

  • The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura

    Nichola Cooper;Roberto Stasi;Susanna Cunningham-Rundles;Michael A. Feuerstein

  • COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City.

    Alain C. Borczuk;Steven P. Salvatore;Surya V. Seshan;Sanjay S. Patel

  • Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia.

    Vivek L. Patel;Matthieu Mahévas;Soo Y. Lee;Roberto Stasi

Frequent Co-Authors

Douglas B. Cines
Douglas B. Cines University of Pennsylvania
Janice G. McFarland
Janice G. McFarland Medical College of Wisconsin
Richard L. Berkowitz
Richard L. Berkowitz Columbia University
Adrian C. Newland
Adrian C. Newland Queen Mary University of London
Charlotte Cunningham-Rundles
Charlotte Cunningham-Rundles Icahn School of Medicine at Mount Sinai
James N. George
James N. George University of Oklahoma Health Sciences Center
Ellis J. Neufeld
Ellis J. Neufeld Boston Children's Hospital
Susanna Cunningham-Rundles
Susanna Cunningham-Rundles Cornell University
Robert McMillan
Robert McMillan Scripps Research Institute
Michael F. Murphy
Michael F. Murphy NHS Blood and Transplant

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Students interested in Biology and Biochemistry have a variety of online degree options that align with careers in healthcare, nutrition, and medical technology. With the rise of flexible online learning, it’s easier than ever to find accredited and cheapest online nutrition degree programs. These paths help prepare students for roles as clinical nutritionists, health educators, or dietitians.

For those drawn to the technology side of healthcare, specialized fields like medical imaging are accessible through online ultrasound tech programs. If you’re considering this career path, explore online ultrasound tech programs—a gateway to certification and rewarding hospital or clinic work.

Completing your education efficiently is also possible with 1 year radiology tech programs online, which can launch a radiologic technologist career in a short timeframe. For further advancement, consider enrolling in one of the best schools for masters in nutrition. These advanced degrees open up leadership and specialized clinical roles.

Best Scientists Citing James B. Bussel

Trending Scientists

Recently Published Articles